Acute chest syndrome natural history, complications and prognosis

	Acute chest syndrome Microchapters
Home
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Acute chest syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acute chest syndrome natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute chest syndrome natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute chest syndrome natural history, complications and prognosis
CDC on Acute chest syndrome natural history, complications and prognosis
Acute chest syndrome natural history, complications and prognosis in the news
Blogs on Acute chest syndrome natural history, complications and prognosis
Directions to Hospitals Treating Acute chest syndrome
Risk calculators and risk factors for Acute chest syndrome natural history, complications and prognosis

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Overall mortality in patients with ACS is 1.8%, however in adults the rate is 4.3%.
There is no difference between patients with Hb SS and Hb SC.
Unfortunately, there have been no presenting signs, symptoms or laboratory data that is predictive of who will die.
A trend to increased mortality has been observed in patients with a lower presenting hemoglobin, multilobar involvement on CXR, and bacteremia.
Patients who die, tend to do so very rapidly and unexpectedly.